MedTrace Logo

3D PET Myocardial Blood Flow and Rb82 Infusion Profiles

NCT05286593 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2023-01-18

No results posted yet for this study

Summary

The investigators seek to test bolus infusions (50ml/min) vs. slow infusions (20 ml/min) of Rb-82 on metrics of coronary blood flow assessed on a modern 3D PET/CT.

Conditions

Interventions

DRUG

Slow Infusion of Rubidium-82

Normal volunteers will receive weight based doses of Rb-82 infused as a slow infusion

DRUG

Slow Infusion of Rubidium-82

Clinical patients will receive weight based doses of Rb-82 infused as a slow infusion

DRUG

Slow Infusion of Rubidium-82

Infarct volunteers will receive weight based doses of Rb-82 infused as a slow infusion

Sponsors & Collaborators

  • Bracco Corporate

    collaborator INDUSTRY

  • Ochsner Health System

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-28
Primary Completion
2022-09-01
Completion
2022-09-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05286593 on ClinicalTrials.gov